Best Philip Nielsen Podcasts (2024)

1
Bahija Jallal, Immunocore 🇬🇧 | Commercial, Diversity, and AI | E14 1:15:45

23d ago1:15:45

1:15:45

We’re super privileged to chat online with Bahija Jallal, the CEO of Immunocore. Immunocore is the largest biotech in the UK and the 5th largest in Europe with a market cap of just over 3 billion dollars. We talk about how Immunocore has helped thousands of cancer patients and has become a commercial biotech. We also talk about why she thinks gende…

1
Edwin Moses | How to build large biotech platforms | E13 1:26:40

2M ago1:26:40

1:26:40

We’re in Brussels with Edwin Moses, the former CEO of one of the most successful platform companies in Europe, Ablynx, now part of Sanofi. We talk about how he feels 5 years after the exit from Ablynx and his lessons. We also talk about the parallels between industrial biotech, AI bio and cell therapy, and how a chairman can help CEOs grow. 💎 ABOUT…

1
Jens Nielsen, BII | How to make translation of life science research work | E12 1:18:34

3M ago1:18:34

1:18:34

We’re in Copenhagen with Jens Nielsen, the CEO of BioInnovation Institute. We will talk about what works best to translate academic research in bio into innovation for humanity, especially how everything is connected. We also talk about how BII is solving some of the main challenges scientist entrepreneurs face and the drawbacks of Novo financing m…

1
Sander van Deventer, VectorY & Forbion | Pioneering gene therapy | E11 59:06

3M ago59:06

59:06

We’re in Amsterdam with Sander van Deventer, the CEO of VectorY. We will talk about VectorY and what’s missing in gene therapy. 💎 ABOUT THE SPEAKERSander has an impressive track record, being a professor, operational biotech founder and a VC. In 1998, he co-founded uniQure, which brought the first gene therapy to the market. He also co-founded the …

1
Thomas Clozel, Owkin | What does AI Biotech really mean | E10 1:20:13

4M ago1:20:13

1:20:13

In an online special, we’re interviewing Thomas Clozal, the co-founder and CEO of Owkin. We talk about scaling AI in biotech and how it feels to be the child of billionaire biotech parents.💎 ABOUT THE SPEAKERThomas founded Owkin in 2016 and I first met him in 2017. At that time, Owkin was still a baby and I wasn’t sure where it would go. Now it’s a…

1
Marc de Garidel, Abivax | How to make two billion 💶 exits ("smoothly") | E09 1:11:33

5M ago1:11:33

1:11:33

Today, I’m in Paris (🇫🇷) to chat with Marc de Garidel, the new CEO of Abivax. We talk about the challenges behind the exits and why Abivax could be a third big success.💎 ABOUT THE SPEAKER Marc is a biopharma veteran with an impressive track record. He has made two billion-dollar exits, was CEO of Ipsen, and has recently made the biggest French IPO …

1
Mike Ward | The Best and the Worst since the 80s in EU Biotech | E08 1:44:25

5M ago1:44:25

1:44:25

Today we're in Munich at BIO-Europe to chat with one of the best commentators in European biotech, Mike Ward. We talk about the best and the worst of the European biotech industry since the 80s.💎 ABOUT THE SPEAKERMike has been in biotech content since the birth of the industry in the 80s. He has worked at BioCentury, Informa/Scrip and now Clarivate…

1
Agnete Fredriksen, Nykode | Being one of the top 50 women in 🇪🇺 bio | E07 1:21:51

6M ago1:21:51

1:21:51

We’re live from Oslo 🇳🇴 to catch up with Agnete Fredriksen, co-founder and CBO of Nykode (ex-Vaccibody). In this episode, we chat about being one of the leading women in bio in Europe, the Nordics, and immunotherapies. 💎 ABOUT THE SPEAKERAgnete founded the immunotherapy company Nykode in 2006 which is now worth around $500M. For her PhD she designe…

1
Rodger Novak, CRISPR Tx | Bringing the first CRISPR drug to the market | E06 1:12:03

6M ago1:12:03

1:12:03

Biotech great Rodger Novak, Co-Founder and Chairman of CRISPR Tx joins us on the show. In this episode, we chat about bringing the first CRISPR drug to the market and why he thinks everything is wrong in bio in Europe besides science. Rodgers’ is a name everyone should know, having made it big in the global biotech scene. I first interviewed him ba…

1
Johannes Fruehauf, BioLabs | Reinventing Incubators For Bio Startups | E05 1:28:43

9M ago1:28:43

1:28:43

We’re back live and in Paris 🇫🇷 with our next guest, Johannes Fruehauf. We talk about reinventing the co-working labs for biotech startups, the difficulties of doing business in Europe, profitability in biotech, and much more (see timestamps below). 💎 ABOUT THE SPEAKER Johannes is the President, CEO, and founder of BioLabs, the biggest “incubator”,…

1
Bernat Olle, Vedanta | Where is the Microbiome Industry Now | E04 1:21:51

10M ago1:21:51

1:21:51

In a virtual special, we welcome Bernat Olle to the show. We discuss the microbiome space, including Vedanta’s upcoming Phase 3, and how it feels to be a European founder in Boston. Bernat is the CEO and co-founder of Boston-based Vedanta Biosciences, one of the leading microbiome companies. They’ve had a positive Phase 2 trial and recently raised …

1
Ingmar Hoerr, CureVac | Founding a $20B Biotech and Almost Dying as CEO | E03 2:31:51

11M ago2:31:51

2:31:51

It’s a treat to welcome Ingmar Hoerr on the show. We chat about building a 20B dollar biotech startup, almost dying on the job, and why people skills are so important in biotech. Ingmar is a pioneer in the EU biotech scene, revolutionizing drug development with mRNA therapeutics. He and his team created the initial technology used in mRNA vaccines …

1
Werner Lanthaler, Evotec | Leading AI in Biotech | E02 1:22:19

1y ago1:22:19

1:22:19

It's great to have Werner Lanthaler, the CEO of Evotec, one of the largest biotech research companies in Europe/the world, on the show. We have known each other for almost ten years now. He's not only sharp but also friendly and easy to talk to. In this episode, we chat about leading AI in biotech, the sharing economy in the industry, how to be aut…

1
Antoine Papiernik, Sofinnova | €Billion Biotech Investing With Balance | E01 44:21

1y ago44:21

44:21

For our first episode, we catch up with Antoine Papiernik, the chairman of Sofinnova partners, one of the top EU biotech VC funds. We chat about building billion-euro biotechs in Europe, being listed on the Midas list (without letting it go to your head), the importance of being good at selling, being lucky, and how to balance all this with family …

Podcasts Worth a Listen

Philip Nielsen Podcasts

Podcasts Worth a Listen

1
Flot.bio x Philip Hemme

Flot.bio

1
Bahija Jallal, Immunocore 🇬🇧 | Commercial, Diversity, and AI | E14 1:15:45

1
Edwin Moses | How to build large biotech platforms | E13 1:26:40

1
Jens Nielsen, BII | How to make translation of life science research work | E12 1:18:34

1
Sander van Deventer, VectorY & Forbion | Pioneering gene therapy | E11 59:06

1
Thomas Clozel, Owkin | What does AI Biotech really mean | E10 1:20:13

1
Marc de Garidel, Abivax | How to make two billion 💶 exits ("smoothly") | E09 1:11:33

1
Mike Ward | The Best and the Worst since the 80s in EU Biotech | E08 1:44:25

1
Agnete Fredriksen, Nykode | Being one of the top 50 women in 🇪🇺 bio | E07 1:21:51

1
Rodger Novak, CRISPR Tx | Bringing the first CRISPR drug to the market | E06 1:12:03

1
Johannes Fruehauf, BioLabs | Reinventing Incubators For Bio Startups | E05 1:28:43

1
Bernat Olle, Vedanta | Where is the Microbiome Industry Now | E04 1:21:51

1
Ingmar Hoerr, CureVac | Founding a $20B Biotech and Almost Dying as CEO | E03 2:31:51

1
Werner Lanthaler, Evotec | Leading AI in Biotech | E02 1:22:19

1
Antoine Papiernik, Sofinnova | €Billion Biotech Investing With Balance | E01 44:21

Quick Reference Guide